Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Working Capital Changes: 2017-2024

Historic Other Working Capital Changes for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $4.3 million.

  • Cogent Biosciences' Other Working Capital Changes rose 230.18% to $1.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.7 million, marking a year-over-year increase of 153.54%. This contributed to the annual value of $4.3 million for FY2024, which is 644.47% up from last year.
  • Per Cogent Biosciences' latest filing, its Other Working Capital Changes stood at $4.3 million for FY2024, which was up 644.47% from -$796,000 recorded in FY2023.
  • Over the past 5 years, Cogent Biosciences' Other Working Capital Changes peaked at $4.3 million during FY2024, and registered a low of -$8.7 million during FY2022.
  • Its 3-year average for Other Working Capital Changes is -$1.7 million, with a median of -$796,000 in 2023.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 333.16% in 2022, then surged by 644.47% in 2024.
  • Yearly analysis of 5 years shows Cogent Biosciences' Other Working Capital Changes stood at $1.5 million in 2020, then soared by 153.54% to $3.7 million in 2021, then crashed by 333.16% to -$8.7 million in 2022, then surged by 90.84% to -$796,000 in 2023, then soared by 644.47% to $4.3 million in 2024.